Logiscreen

Dyne Therapeutics Inc

$18.21
Market Cap 3.01B
ROE -64.3%
Gross Margin 0.0%
Debt/Equity 0.3
Current Ratio 12.0
Revenue QoQ 0.0%
EPS QoQ 0.1%
F-Score 2

About

Dyne Therapeutics Inc

Exchange
NASDAQ
Sector
Utilities
Industry
Utilities - Regulated Electric

Sector context

Utilities

Undervalued

Trading at a discount to sector peers

P/E
-8.87
vs median 17.60
P/B
4.63
vs median 1.74
ROE
-0.58
vs median 0.10

Lower quality - review fundamentals carefully

Mid-cap company with growth potential

Similar companies

XEMIREEWRMGEEHE
Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics